Bio

Anthony Marsico has over 25 years of experience representing publicly traded and closely-held domestic and foreign corporations across a wide range of industries, including life sciences, medical device, pharmaceutical, cannabis, technology, manufacturing, retail, food & beverage and financial services, as well as leading financial institutions, investment banks, broker-dealers, trading firms, private equity firms, hedge funds and other private investors, in a broad range of equity and debt capital markets transactions, including initial public offerings, fully marketed and “alternative” or “hybrid” follow-on public securities offerings (including registered-direct offerings and confidentially marketed or “wall-cross” public offerings), “overnight” or “bought” deals, at-the-market offerings (ATMs), public and privately placed “equity-line of credit” financings, traditional and structured equity and debt private investments in public companies (PIPEs), debt-for-equity exchanges, and a variety of cross-border securities offerings. He also regularly advises clients on U.S. federal securities law matters and disclosure requirements, as well as other general corporate law matters. In addition to his capital markets experience, Anthony has extensive experience representing public and private companies, boards of directors, special committees, controlling stockholders, private equity investors and sponsors, management buyout groups, hedge funds, financial advisors, and investment banking firms in strategic and financial mergers and acquisitions, business combinations, and corporate control contests.